NEXT Financial Group, Inc - REPROS THERAPEUTICS INC ownership

REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 62 filers reported holding REPROS THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.

Quarter-by-quarter ownership
NEXT Financial Group, Inc ownership history of REPROS THERAPEUTICS INC
ValueSharesWeighting
Q1 2016$03000.0%0.00%
Q4 2015$0
-100.0%
300
-68.4%
0.00%
-100.0%
Q3 2015$7,000
+16.7%
9500.0%0.00%
+50.0%
Q2 2015$6,0000.0%950
+18.8%
0.00%0.0%
Q1 2015$6,000
-53.8%
800
-38.5%
0.00%
-50.0%
Q4 2014$13,000
-65.8%
1,300
-66.2%
0.00%
-50.0%
Q3 2014$38,0003,8500.01%
Other shareholders
REPROS THERAPEUTICS INC shareholders Q3 2015
NameSharesValueWeighting ↓
Allegis Investment Advisors, LLC 342,709$569,0000.29%
GENERAL AMERICAN INVESTORS CO INC 396,123$638,0000.07%
Alambic Investment Management, L.P. 69,191$111,0000.03%
Acrospire Investment Management LLC 15,119$24,0000.02%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 98,486$158,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 315,030$507,0000.01%
SIMPLEX TRADING, LLC 86,054$138,0000.01%
A.R.T. Advisors, LLC 34,315$55,0000.00%
Mariner Wealth Advisors-Cincinnati, LLC 11,000$18,0000.00%
Renaissance Technologies 561,713$904,0000.00%
View complete list of REPROS THERAPEUTICS INC shareholders